Cita APA (7a ed.)
K, S., N, Y., G, R., F, L., PA, v. D., R, v. K., & PIM, S. (2004). Effect of methylprednisolone in patients with Guillain-Barré syndrome...van Koningsveld R, Schmitz PIM, van der Meché FGA et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: Randomised trial. Lancet 2004; 363:192-96. Lancet, 363(9416), 1236-1239.
Cita Chicago Style (17a ed.)
K, Susuki, Yuki N, Rossi G, Locatelli F, van Doorn PA, van Koningsveld R, y Schmitz PIM. "Effect of Methylprednisolone in Patients with Guillain-Barré Syndrome...van Koningsveld R, Schmitz PIM, Van Der Meché FGA Et Al. Effect of Methylprednisolone When Added to Standard Treatment with Intravenous Immunoglobulin for Guillain-Barré Syndrome: Randomised Trial. Lancet 2004; 363:192-96." Lancet 363, no. 9416 (2004): 1236-1239.
Cita MLA (9a ed.)
K, Susuki, et al. "Effect of Methylprednisolone in Patients with Guillain-Barré Syndrome...van Koningsveld R, Schmitz PIM, Van Der Meché FGA Et Al. Effect of Methylprednisolone When Added to Standard Treatment with Intravenous Immunoglobulin for Guillain-Barré Syndrome: Randomised Trial. Lancet 2004; 363:192-96." Lancet, vol. 363, no. 9416, 2004, pp. 1236-1239.
Precaución: Estas citas no son 100% exactas.